These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25254376)

  • 21. Planning for the next influenza H1N1 season: a modelling study.
    Carrat F; Pelat C; Levy-Bruhl D; Bonmarin I; Lapidus N
    BMC Infect Dis; 2010 Oct; 10():301. PubMed ID: 20964814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revealing the True Incidence of Pandemic A(H1N1)pdm09 Influenza in Finland during the First Two Seasons - An Analysis Based on a Dynamic Transmission Model.
    Shubin M; Lebedev A; Lyytikäinen O; Auranen K
    PLoS Comput Biol; 2016 Mar; 12(3):e1004803. PubMed ID: 27010206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza pandemic (H1N1) 2009 activity during summer 2009. Effectiveness of the 2008-9 trivalent vaccine against pandemic influenza in Spain.
    Larrauri A; Savulescu C; Jiménez-Jorge S; Pérez-Breña P; Pozo F; Casas I; Ledesma J; de Mateo S;
    Gac Sanit; 2011; 25(1):23-8. PubMed ID: 21334788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transmissibility and severity of the pandemic influenza A (H1N1) 2009 virus in Spain].
    Simón Méndez L; de Mateo Ontañón S; Larrauri Cámara A; Jiménez-Jorge S; Vaqué Rafart J; Pérez Hoyos S;
    Gac Sanit; 2011; 25(4):296-302. PubMed ID: 21543138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons.
    Bonmarin I; Belchior E; Bergounioux J; Brun-Buisson C; Mégarbane B; Chappert JL; Hubert B; Le Strat Y; Lévy-Bruhl D
    Euro Surveill; 2015; 20(46):. PubMed ID: 26607262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influenza surveillance in nine consecutive seasons, 2003-2012: results from National Influenza Reference Laboratory, Istanbul Faculty Of Medicine, Turkey].
    Akçay Ciblak M; Kanturvardar Tütenyurd M; Asar S; Tulunoğlu M; Fındıkçı N; Badur S
    Mikrobiyol Bul; 2012 Oct; 46(4):575-93. PubMed ID: 23188572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries.
    Beauté J; Broberg E; Plata F; Bonmarin I; O Donnell J; Delgado C; Boddington N; Snacken R
    Euro Surveill; 2012 Mar; 17(9):. PubMed ID: 22401564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Pozo F; Casado I; Guevara M; Martínez-Baz I; Barricarte A; Ezpeleta C; ;
    Vaccine; 2016 Mar; 34(11):1350-7. PubMed ID: 26854911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
    J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.
    Skowronski DM; Leir S; De Serres G; Murti M; Dickinson JA; Winter AL; Olsha R; Croxen MA; Drews SJ; Charest H; Martineau C; Sabaiduc S; Bastien N; Li Y; Petric M; Jassem A; Krajden M; Gubbay JB
    Euro Surveill; 2019 Apr; 24(15):. PubMed ID: 30994107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolutionary analysis of influenza A(H1N1)pdm09 during the pandemic and post-pandemic period in Pakistan.
    Badar N; Salman M; Aamir UB; Ansari J; Ranjha MA; Khan MA; Ikram A; Nisar N; Mushtaq N; Mirza HA
    J Infect Public Health; 2020 Mar; 13(3):407-413. PubMed ID: 31000492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of the 2009 influenza pandemic in Spain. The Spanish Influenza Surveillance System.
    Larrauri Cámara A; Jiménez-Jorge S; Mateo Ontañón Sd; Pozo Sánchez F; Ledesma Moreno J; Casas Flecha I;
    Enferm Infecc Microbiol Clin; 2012 Oct; 30 Suppl 4():2-9. PubMed ID: 23116786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus.
    Martínez-Baz I; Casado I; Navascués A; Díaz-González J; Aguinaga A; Barrado L; Delfrade J; Ezpeleta C; Castilla J
    J Infect Dis; 2017 Mar; 215(6):847-855. PubMed ID: 28453845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region.
    Colucci ME; Veronesi L; Bracchi MT; Zoni R; Caruso L; Capobianco E; Rossi D; Bizzarro A; Cantarelli A; Affanni P
    Acta Biomed; 2019 Sep; 90(9-S):21-27. PubMed ID: 31517886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011.
    Suess T; Remschmidt C; Schink SB; Schweiger B; Nitsche A; Schroeder K; Doellinger J; Milde J; Haas W; Koehler I; Krause G; Buchholz U
    BMC Infect Dis; 2012 Jan; 12():26. PubMed ID: 22280120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.
    Castilla J; Morán J; Martínez-Artola V; Fernández-Alonso M; Guevara M; Cenoz MG; Reina G; Alvarez N; Arriazu M; Elía F; Salcedo E; Barricarte A;
    Vaccine; 2011 Aug; 29(35):5919-24. PubMed ID: 21723358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of symptomatic A(H1N1)pdm09 influenza during the pandemic and post-pandemic periods in a rural Indian community.
    Fowler KB; Gupta V; Sullender W; Broor S; Widdowson MA; Lal RB; Krishnan A
    Int J Infect Dis; 2013 Dec; 17(12):e1182-5. PubMed ID: 24103331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.